156 related articles for article (PubMed ID: 22277624)
1. Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as T₂ MRI contrast agents.
Kattel K; Park JY; Xu W; Kim HG; Lee EJ; Bony BA; Heo WC; Jin S; Baeck JS; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
Biomaterials; 2012 Apr; 33(11):3254-61. PubMed ID: 22277624
[TBL] [Abstract][Full Text] [Related]
2. A facile synthesis, in vitro and in vivo MR studies of d-glucuronic acid-coated ultrasmall Ln₂O₃ (Ln = Eu, Gd, Dy, Ho, and Er) nanoparticles as a new potential MRI contrast agent.
Kattel K; Park JY; Xu W; Kim HG; Lee EJ; Bony BA; Heo WC; Lee JJ; Jin S; Baeck JS; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
ACS Appl Mater Interfaces; 2011 Sep; 3(9):3325-34. PubMed ID: 21853997
[TBL] [Abstract][Full Text] [Related]
3. Dual-mode T1 and T2 magnetic resonance imaging contrast agent based on ultrasmall mixed gadolinium-dysprosium oxide nanoparticles: synthesis, characterization, and in vivo application.
Tegafaw T; Xu W; Ahmad MW; Baeck JS; Chang Y; Bae JE; Chae KS; Kim TJ; Lee GH
Nanotechnology; 2015 Sep; 26(36):365102. PubMed ID: 26291827
[TBL] [Abstract][Full Text] [Related]
4. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
[TBL] [Abstract][Full Text] [Related]
5. Water-soluble superparamagnetic magnetite nanoparticles with biocompatible coating for enhanced magnetic resonance imaging.
Xiao L; Li J; Brougham DF; Fox EK; Feliu N; Bushmelev A; Schmidt A; Mertens N; Kiessling F; Valldor M; Fadeel B; Mathur S
ACS Nano; 2011 Aug; 5(8):6315-24. PubMed ID: 21790153
[TBL] [Abstract][Full Text] [Related]
6. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
[TBL] [Abstract][Full Text] [Related]
7. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
8. Amphiphilic polymer-coated hybrid nanoparticles as CT/MRI dual contrast agents.
Kim D; Yu MK; Lee TS; Park JJ; Jeong YY; Jon S
Nanotechnology; 2011 Apr; 22(15):155101. PubMed ID: 21389582
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Magnetic Properties, Map Images, and Water Proton Relaxivities of D-Glucuronic Acid Coated Ln2O3 Nanoparticles (Ln = Ho and Er).
Kattel K; Kim CR; Xu W; Kim TJ; Park JW; Chang Y; Lee GH
J Nanosci Nanotechnol; 2015 Sep; 15(9):7311-6. PubMed ID: 26716328
[TBL] [Abstract][Full Text] [Related]
10. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
Hu F; Jia Q; Li Y; Gao M
Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
[TBL] [Abstract][Full Text] [Related]
12. New Class of Efficient T
Yue H; Park JA; Ho SL; Ahmad MY; Cha H; Liu S; Tegafaw T; Marasini S; Ghazanfari A; Kim S; Chae KS; Chang Y; Lee GH
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33076332
[TBL] [Abstract][Full Text] [Related]
13. Tuning of the size of Dy2O3 nanoparticles for optimal performance as an MRI contrast agent.
Norek M; Kampert E; Zeitler U; Peters JA
J Am Chem Soc; 2008 Apr; 130(15):5335-40. PubMed ID: 18355014
[TBL] [Abstract][Full Text] [Related]
14. Relaxation behavior study of ultrasmall superparamagnetic iron oxide nanoparticles at ultralow and ultrahigh magnetic fields.
Wang W; Dong H; Pacheco V; Willbold D; Zhang Y; Offenhaeusser A; Hartmann R; Weirich TE; Ma P; Krause HJ; Gu Z
J Phys Chem B; 2011 Dec; 115(49):14789-93. PubMed ID: 21972868
[TBL] [Abstract][Full Text] [Related]
15. Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging.
Ericsson A; Bach-Gansmo T; Niklasson F; Hemmingsson A
Acta Radiol; 1995 Jan; 36(1):41-6. PubMed ID: 7833167
[TBL] [Abstract][Full Text] [Related]
16. Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.
Zeng L; Ren W; Zheng J; Cui P; Wu A
Phys Chem Chem Phys; 2012 Feb; 14(8):2631-6. PubMed ID: 22273844
[TBL] [Abstract][Full Text] [Related]
17. Magnetite-loaded fluorine-containing polymeric micelles for magnetic resonance imaging and drug delivery.
Li X; Li H; Liu G; Deng Z; Wu S; Li P; Xu Z; Xu H; Chu PK
Biomaterials; 2012 Apr; 33(10):3013-24. PubMed ID: 22243798
[TBL] [Abstract][Full Text] [Related]
18. Water-soluble d-glucuronic acid coated ultrasmall mixed Ln/Mn (Ln = Gd and Dy) oxide nanoparticles and their application to magnetic resonance imaging.
Bony BA; Baeck JS; Chang Y; Bae JE; Chae KS; Lee GH
Biomater Sci; 2014 Sep; 2(9):1287-1295. PubMed ID: 32481899
[TBL] [Abstract][Full Text] [Related]
19. Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T2 contrast enhancement in magnetic resonance imaging.
Herman DA; Ferguson P; Cheong S; Hermans IF; Ruck BJ; Allan KM; Prabakar S; Spencer JL; Lendrum CD; Tilley RD
Chem Commun (Camb); 2011 Aug; 47(32):9221-3. PubMed ID: 21761066
[TBL] [Abstract][Full Text] [Related]
20. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
Huang G; Li H; Chen J; Zhao Z; Yang L; Chi X; Chen Z; Wang X; Gao J
Nanoscale; 2014 Sep; 6(17):10404-12. PubMed ID: 25079966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
